|
WO2021081480A2
|
|
Improved vaccines for recurrent respiratory papillomatosis and methods for using the same
|
|
WO2021051065A1
|
|
Tert, wt-1, pmsa immunogenic compositions and methods of treatment using the same
|
|
AU2019215006A1
|
|
Nucleic acid antibody constructs for use against respiratory syncytial virus
|
|
KR20200096955A
|
|
Cancer vaccines targeting mesothelin and uses thereof
|
|
KR20200096956A
|
|
Cancer vaccines targeting PRAME and uses thereof
|
|
KR20200096954A
|
|
Cancer vaccines targeting BORIS and uses thereof
|
|
WO2019118764A1
|
|
Cancer vaccines targeting muc16 and uses thereof
|
|
KR20200096957A
|
|
Cancer vaccines targeting survivin and uses thereof
|
|
KR20200096959A
|
|
Cancer vaccine targeting LEMD1 and uses thereof
|
|
BR112019023555A2
|
|
Clinical and immunological biomarkers for high degree cervical dysplasia regulations and depuration of hpv 16 and hpv 18 infection after immunotherapy
|
|
BR112019020235A2
|
|
nucleic acid molecule, composition, and methods for treating a disease in an individual and for inducing an immune response in an individual.
|
|
AU2017336088A1
|
|
Tert immunogenic compositions and methods of treatment using the same
|
|
MX2019003335A
|
|
Method and device for minimally invasive in vivo transfection of adipose tissue using electroporation.
|
|
AU2017329044A1
|
|
Combination of novel vaccines against Zika virus and DNA antibody constructs for use against Zika virus
|
|
CN109415714A
|
|
Enhance the delivering of medicament using chondroitinase and/or hyaluronidase in vivo
|
|
KR20180108793A
|
|
Cancer vaccine and therapeutic method using the same
|
|
KR20180099751A
|
|
An electroporation device having a needle array detachable by a lock-out system
|
|
CN108601528A
|
|
Intradermal jet injection type electroporation device
|
|
EP3397335A1
|
|
Electroporation device with improved signal generator
|
|
BR112018012900A2
|
|
electroporation device that has a battery pack with power switch
|
